安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
- Regeneron Pharmaceuticals - Wikipedia
Regeneron has developed aflibercept, a VEGF inhibitor, and rilonacept, an interleukin-1 blocker VEGF is a protein that normally stimulates the growth of blood vessels, and interleukin-1 is a protein that is normally involved in inflammation
- Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to . . .
TARRYTOWN, N Y , June 02, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) today announced interim results from the ongoing Phase 2 COURAGE trial investigating novel combinations of semaglutide (GLP-1 receptor agonist) and trevogrumab (anti-GDF8 anti-myostatin) with or without garetosmab (anti-activin A) for the treatment
- Clinical Trials Home | Regeneron Pharmaceuticals
Search for a Regeneron clinical trial based on condition, keyword, and location Explore comprehensive information on our highlighted trials to learn more
- Regeneron declines to make higher bid for 23andMe after Wojcickis $305 . . .
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday
- Sanofi, Regeneron Get FDA Approval for Dupixent to Treat Rare Skin . . .
Sanofi and Regeneron Pharmaceuticals said they got Food and Drug Administration approval for anti-inflammatory drug Dupixent as a treatment for a rare skin disease, adding an eighth indication in
- Regeneron Pharmaceuticals (REGN) Stock Price Overview
Regeneron Pharmaceuticals, Inc discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide The company’s products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular
- About Regeneron | Our Company
Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases
|
|
|